| Line Item | 2025-09-27 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $145.8M | +14.3% | -24.6% |
| Cost of Revenue | $100.6M | +12.7% | -23.3% |
| Gross Profit | $45.3M | +18.2% | -27.5% |
| R&D Expense | $13.1M | -4.9% | -33.3% |
| SG&A Expense | $29.3M | -25.0% | -0.0% |
| Operating Income | -$17.7M | +51.9% | -343.5% |
| Interest Expense | $1.6M | -68.6% | -70.4% |
| Pre-tax Income | -$18.4M | +21.2% | -247.4% |
| Income Tax | $3.1M | +701.1% | +191.1% |
| Net Income | -$21.5M | +5.6% | -237.9% |
| EPS (Basic) | -$0.62 | +8.8% | -195.2% |
| EPS (Diluted) | -$0.62 | +8.8% | -195.2% |
| Line Item | 2025-09-27 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $24.8M | -38.8% | -75.0% |
| Accounts Receivable | $56.8M | +1.3% | -43.9% |
| Inventory | $140.9M | +59.7% | -5.5% |
| Current Assets | $248.5M | +1.5% | -41.4% |
| Total Assets | $481.6M | +0.3% | -28.1% |
| Current Liabilities |
| Line Item | 2025-09-27 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$104.2M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $580K | — | — |
| Financing Cash Flow | -$4.4M | — | — |
| Free Cash Flow | -$104.2M | — | — |
| $480.9M |
| +5.3% |
| +64.3% |
| Total Liabilities | $508.5M | +4.2% | -2.2% |
| Stockholders' Equity | -$26.9M | -249.5% | -117.9% |